According to a recent report released by the Centers for Medicare and Medicaid Services (CMS), almost 16 percent of residents at long-term nursing homes are being treated with antipsychotic medications. While down from 24 percent in 2011, the CMS report and many doctors question the efficacy and necessity of these powerful mind-altering medications. According to the report, decreases in antipsychotic usage were seen across all fifty states, with New York seeing one of the smallest reductions.
The majority of elderly residents receiving the antipsychotic medicine are diagnosed with dementia. Antipsychotic drugs, such as Abilify, Seroquel, Risperdal, and Zyprexa, have not been proven to treat dementia, nor have these drugs been shown to reduce the symptoms of dementia. In some instances, antipsychotic medication can also cause serious side effects for the senior citizens who have been prescribed these drugs. In addition to a higher rate of death, antipsychotic drugs also increase the risk of cardiovascular disease and slip and fall accidents. Consequently, medical associations and patient advocacy groups believe the number of dementia patients taking antipsychotics should be closer to zero. Continue reading